Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis
- PMID: 33418022
- DOI: 10.1016/j.cmi.2020.12.035
Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis
Abstract
Objectives: Pulmonary mucormycosis (PM) is increasingly being reported in immunocompromised patients and has a high mortality. Our aim was to assess the mortality of PM and its trend over time. We also evaluated the role of combined medical-surgical therapy in PM.
Methods: We performed a systematic review of Pubmed, Embase, and Cochrane central databases. Studies were eligible if they described at least five confirmed cases of PM and reported mortality. We also assessed the effect of combined medical-surgical therapy versus medical treatment alone on PM mortality. We used a random-effects model to estimate the pooled mortality of PM and compared it across three time periods. The factors influencing mortality were assessed using meta-regression. We evaluated the risk difference (RD) of death in the following: subjects undergoing combined medical-surgical therapy versus medical therapy alone, subjects with isolated PM versus disseminated disease, and PM in diabetes mellitus (DM) versus non-DM as a risk factor.
Results: We included 79 studies (1544 subjects). The pooled mortality of PM was 57.1% (95% confidence interval [CI] 51.7-62.6%). Mortality improved significantly over time (72.1% versus 58.3% versus 49.8% for studies before 2000, 2000-2009, and 2010-2020, respectively, p 0.00001). This improved survival was confirmed in meta-regression after adjusting for the study design, the country's income level, and the sample size. Combined medical-surgical therapy was associated with a significantly lower RD (95%CI) of death: -0.32 (-0.49 to -0.16). The disseminated disease had a higher risk of death than isolated PM, but DM was not associated with a higher risk of death than other risk factors.
Conclusions: While PM is still associated with high mortality, we noted improved survival over time. Combined medical-surgical therapy improved survival compared to medical treatment alone.
Keywords: Fungal pneumonia; Lung surgery; Mucorales; Reversed halo sign; Zygomycosis.
Copyright © 2021 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India.Clin Microbiol Infect. 2020 Jul;26(7):944.e9-944.e15. doi: 10.1016/j.cmi.2019.11.021. Epub 2019 Dec 4. Clin Microbiol Infect. 2020. PMID: 31811914
-
Pulmonary Mucormycosis: Risk Factors, Radiologic Findings, and Pathologic Correlation.Radiographics. 2020 May-Jun;40(3):656-666. doi: 10.1148/rg.2020190156. Epub 2020 Mar 20. Radiographics. 2020. PMID: 32196429 Review.
-
[Retrospective study of 25 cases of pulmonary mucormycosis in acute leukaemia].Rev Mal Respir. 2018 Apr;35(4):452-464. doi: 10.1016/j.rmr.2017.11.009. Epub 2018 May 10. Rev Mal Respir. 2018. PMID: 29754839 Review. French.
-
Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome.Infection. 2018 Aug;46(4):503-512. doi: 10.1007/s15010-018-1149-x. Epub 2018 May 10. Infection. 2018. PMID: 29748841
-
Mucormycosis.Semin Respir Crit Care Med. 2020 Feb;41(1):99-114. doi: 10.1055/s-0039-3401992. Epub 2020 Jan 30. Semin Respir Crit Care Med. 2020. PMID: 32000287 Review.
Cited by
-
Clinical Manifestations of Pulmonary Mucormycosis in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: A 21-Case Series Report and Literature Review.Can Respir J. 2022 Jun 2;2022:1237125. doi: 10.1155/2022/1237125. eCollection 2022. Can Respir J. 2022. PMID: 35692949 Free PMC article. Review.
-
Risk Based Decision Algorithms for Management of COVID-19 Associated Rhino-orbital Mucormycosis.Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3447-3454. doi: 10.1007/s12070-021-02692-9. Epub 2021 Jul 30. Indian J Otolaryngol Head Neck Surg. 2022. PMID: 34367935 Free PMC article.
-
Very severe aplastic anemia in a child with pulmonary mucormycosis: a case report.Front Pediatr. 2024 Sep 12;12:1453059. doi: 10.3389/fped.2024.1453059. eCollection 2024. Front Pediatr. 2024. PMID: 39328586 Free PMC article.
-
Epidemiology and prognostic factors of mucormycosis in France (2012-2022): a cross-sectional study nested in a prospective surveillance programme.Lancet Reg Health Eur. 2024 Aug 7;45:101010. doi: 10.1016/j.lanepe.2024.101010. eCollection 2024 Oct. Lancet Reg Health Eur. 2024. PMID: 39220434 Free PMC article.
-
Reader comments : Antifungal combinations in mucormycosis.Proc (Bayl Univ Med Cent). 2022 Apr 19;35(3):403. doi: 10.1080/08998280.2022.2039029. eCollection 2022. Proc (Bayl Univ Med Cent). 2022. PMID: 35518800 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous